Harold Alvarez
Anatomic Pathology & Clinical Pathology · Miami, FLNPI 1083767040
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Cerus Corporation accounts for 74.1% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2020 at $2,099 and has fallen 83.4% since, to $348 in 2025. Among anatomic pathology & clinical pathology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $180.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cerus Corporation$3K
- Sanofi$251
- Bristol Myers Squibb$162
- Gamida Cell Inc.$125
- Novartis$125
- Astellas Pharma US Inc$99
- plus $358 from 10 others
Across 3 payments — averaging $43,518 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Beckman Coulter, Inc.$70K
- Sekisui Diagnostics LLC$60K
What the payments were for
- Speaking & faculty fees$2,50058%
- Travel & lodging$70116%
- Food & beverage$1,02124%
- Education$992%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cerus Corporation | 4 | $3,201 |
| Sanofi | 2 | $251 |
| Bristol Myers Squibb | 1 | $162 |
| Gamida Cell Inc. | 1 | $125 |
| Novartis | 1 | $125 |
| Astellas Pharma US Inc | 1 | $99 |
| Adaptive Biotechnologies Corporation | 2 | $65 |
| Johnson & Johnson | 2 | $50 |
| Blueprint Medicines Corporation | 2 | $48 |
| Gilead | 2 | $44 |
| Seagen Inc. | 1 | $36 |
| AstraZeneca | 1 | $29 |
| Sobi, Inc | 1 | $29 |
| Argenx US, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Incyte Corporation | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEVICE-TRANSFUSION$3,201
- SARCLISA$251
- OMISIRGE$125
- GLEEVEC$125
How this compares
$4,322 in reported general payments places this provider in the 90th percentile of 510 anatomic pathology & clinical pathology providers in Florida.
See all anatomic pathology & clinical pathology providers in Florida →
Other anatomic pathology & clinical pathology in Miami
- Hadi YazijiMiami$34K
- Elizabeth MontgomeryMiami$32K
- Julio Diaz-PerezMiami$18K
- Aileen MartyMiami$8K
- Deepan MathurMiami$4K
- Monica Garcia-BuitragoMiami$3K
- David AndrewsMiami$2K
- Gary ProcopMiami$2K
- Alan SchillerMiami$2K
- Yi ZhouMiami$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.